Loading clinical trials...
Loading clinical trials...
Biomarker for Niemann Pick Type C Disease (NPC1/NPC2) an International, Multicenter, Epidemiological Study
Conditions
Locations
4
Germany
Centogene AG
Rostock, Germany
Amrita Institute of Medical Sciences & Research Centre
Kochi, Kerala, India
Navi Mumbai Institute of Research In Mental And Neurological Handicap (NIRMAN)
Mumbai, India
Lady Ridgeway Hospital for Children
Colombo, Sri Lanka
Start Date
August 20, 2018
Primary Completion Date
February 28, 2021
Completion Date
February 28, 2021
Last Updated
February 13, 2023
NCT07545473
NCT03333200
NCT05641103
NCT03879655
NCT04958642
NCT01372228
Lead Sponsor
CENTOGENE GmbH Rostock
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions